96. クローン病 Crohn disease Clinical trials / Disease details

臨床試験数 : 2,442 / 薬物数 : 1,278 - (DrugBank : 248) / 標的遺伝子数 : 142 - 標的パスウェイ数 : 209

3 trials found

diseases per page:

Showing 1 to 3 of 3 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01355614 (ClinicalTrials.gov)	June 2011	16/5/2011	A Phase II Efficacy Study in Fistulizing Crohn's Disease Patients	A Multi-center, Randomized, Double-blind, Active Controlled Study to Assess Efficacy, Safety and Tol ...	Crohn's Disease	Drug: QAX576;Drug: Infliximab	Novartis Pharmaceuticals	NULL	Completed	18 Years	N/A	All	10	Phase 2	Germany;Switzerland
2	EUCTR2010-019973-13-DE (EUCTR)	14/01/2011	30/09/2010	A Phase II Efficacy Study in Fistulizing Crohn's Disease Patients	A multi-center, randomized, double-blind, active controlled study to assess efficacy, safety and tol ...	Treatment of perianal fistulas in patients suffering from Crohn's Disease. MedDRA version: 14.0;Leve ...	Product Code: QAX576 Trade Name: Remicade INN or Proposed INN: INFLIXIMAB	Novartis Pharma AG	NULL	Not Recruiting			Female: yes Male: yes	23	Phase 2	Germany;Switzerland
3	NCT01316601 (ClinicalTrials.gov)	January 2011	14/3/2011	A Study to Assess Efficacy, Safety and Tolerability of the Anti-IL-13 Monoclonal Antibody QAX576in t ...		Crohn's Disease	Drug: QAX567	Gerhard Rogler	Novartis Pharmaceuticals	Completed	18 Years	N/A	Both	3	Phase 2	Switzerland

First Previous1Next Last